1. Pathophysiologic Mechanisms Leading to the Development of Hyperglycemia

2. UKPDS 34: Metformin vs Conventional Glycemic Control on Outcomes

3. Metformin Use in T2DM Patients With CKD

4. Newer Oral Pharmacologic Options for the Management of Hyperglycemia

5. VERIFY: Vildagliptin and Metformin Early Initiation vs Standard Metformin Initiation

6. Notable Side Effects With Oral Antihyperglycemic Agents

7. SAVOR-TIMI 53: Mortality and CV Outcomes

8. Notable Side Effects With Oral Antihyperglycemic Agents (cont)

9. ABCD Management of T2DM: A Personalized Approach